Compare ResMed Inc. (RMD) vs Vanguard High Dividend Yield ETF (VYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Vanguard High Dividend Yield ETF — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Vanguard High Dividend Yield ETF trades at $160.42. The key difference: ResMed Inc. pays a 1.21% dividend while Vanguard High Dividend Yield ETF pays none, and Vanguard High Dividend Yield ETF is trading nearer its 52-week high, ResMed Inc. nearer its low. Which is the better fit depends on your goals.
| RMD | VYM | |
|---|---|---|
Market Cap | $28.81B | — |
Sector | Health | — |
52-Week High | $293.73 | $161.17 |
52-Week Low | $182.82 | $132.90 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VYM trades at $159.41, down 0.47% on the day, with a bullish technical signal from moving averages and neutral oscillators. The ETF holds $94.6 billion in assets, emphasizing high dividend yield from U.S. large-cap stocks. Recent news highlights institutional buying and its role in retirement income strategies, with a dividend of $0.98 scheduled for June 2026.
Outlook remains positive for income-focused investors due to broad diversification and low costs, though risks include interest rate sensitivity and market volatility. The ETF's appeal lies in steady cash flow, but competition from higher-yielding funds poses a challenge to outperformance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Vanguard High Dividend Yield ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →
